Ligneous conjunctivitis and use of human plasminogen eyedrops: The Italian experience
Haemophilia
.
2023 Mar;29(2):681-684.
doi: 10.1111/hae.14745.
Epub 2023 Jan 19.
Authors
Maria T Sartori
1
,
Andrea Bartuli
2
,
Simona M Siboni
3
,
Andrea Leonardi
4
,
Paola Valente
5
,
Jacopo Secci
6
,
Fabiana Cortellessa
2
,
Roberto Caputo
6
Affiliations
1
Clinical Medicine I, Department of Medicine, Padua University Hospital, Padua, Italy.
2
UOC Rare Diseases and Medical Genetics, University Pediatric Department, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
3
Fondazione IRCCS Ca' Granda, Policlinico Hospital, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
4
Ophthalmology Unit, Department of Neuroscience, University of Padua, Padua, Italy.
5
UOC Ophthalmology, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy.
6
Pediatric Ophthalmology Unit, A. Meyer Children's Hospital, Florence, Italy.
PMID:
36657104
DOI:
10.1111/hae.14745
No abstract available
Publication types
Letter
Comment
MeSH terms
Conjunctivitis*
Humans
Italy / epidemiology
Ophthalmic Solutions / therapeutic use
Plasminogen
Substances
Ophthalmic Solutions
Plasminogen
Supplementary concepts
Plasminogen Deficiency, Type I